Holly Goodman

Associate Vice President, Analytics at Payer Sciences

Holly Goodman has a diverse work experience spanning multiple industries. Holly is currently working as the Associate Vice President of Analytics at Payer Sciences since May 2023. Previously, they founded and owned Tri-Math in 2016. Holly also held various positions at Optum, including Director of Strategic Market Advancement from November 2021 to May 2023, Associate Director from February 2020 to November 2021, and Manager from June 2018 to February 2020. Additionally, they worked as a Data Scientist at Atlantic Health from November 2015 to June 2018 and as a Financial Analyst at Dun and Bradstreet from June 2014 to October 2015. Holly also gained experience as a Summer Associate at CIBC in 2013, a Summer Intern at RegentAtlantic Capital, LLC in 2012, a Team Lead at Marshal Salant Investment Team from August 2011 to May 2012, and an Intern at Deutsche Bank in 2011. Holly began their career as an Assistant Editor at Worth Publishers from November 2010 to January 2011.

Holly Goodman pursued their education starting in 2000 at Kent Place School, although specific degree or field of study information is not available for this period. From 2009 to 2012, they attended The Johns Hopkins University, where they obtained a Bachelor of Science and a Bachelor of Arts degree in Applied Math and Statistics and Economics, respectively. Following this, they pursued a Master's degree in Finance at Princeton University from 2012 to 2014, specializing in Quantitative Finance.

Location

New York, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices


Payer Sciences

Tasked with tackling a labyrinth of payers and organized customers, with limited resources, payer marketers can sometimes feel trapped between a rock and—well…you know. Which is why our clients need an agency that knows how to rock in a hard space. Since day one, Payer Sciences has approached managed markets from a different angle. We firmly believe the truth lies in the data. We relentlessly analyze what formulary decision-makers and prescribers actually do, revealing patterns and practices that impact stakeholders across the treatment journey, and drive bottom-line results. This disciplined approach requires an investment in sharp minds and multiple perspectives. To that end, Payer Sciences has assembled a flat and flexible organization, with analytics, consulting and communications living together under one roof—as one fully aligned team—so that we’re always ready to rock. No matter how hard the space. Payer Sciences is part of Publicis Health North America, and a subsidiary of the Publicis Group (OTCQX: PUBGY).


Industries

Employees

51-200

Links